SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

FRE

38.8

-0.33%↓

PHIA

21.75

-1.27%↓

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

FRE

38.8

-0.33%↓

PHIA

21.75

-1.27%↓

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

FRE

38.8

-0.33%↓

PHIA

21.75

-1.27%↓

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

FRE

38.8

-0.33%↓

PHIA

21.75

-1.27%↓

SAN

73.96

+1.25%↑

ARGX

691.6

+0.03%↑

SHL.DE

33.51

-1.93%↓

FRE

38.8

-0.33%↓

PHIA

21.75

-1.27%↓

Home・Aandelen Lijst・Merck KGaA

Merck KGaA

Gesloten

SectorGezondheidszorg

116.65 -3.2

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

116.45

Max

118.85

Belangrijke statistieken
By Trading Economics
Inkomsten	250M 902M
Verkoop	63M 5.3B
Dividendrendement	1.34
Winstmarge	16.961

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+13.91% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.34% 2.34%
Volgende Winsten	6 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	98B
Vorige openingsprijs	119.85
Vorige sluitingsprijs	116.65

Nieuwssentiment

By Acuity

35%

65%

108 / 345 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

121.15 / 123.55 Steun & Weerstand

Merck KGaA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mei 2026, 10:19 UTC

Winsten

Belangrijke Marktbewegers

Germany's Merck KGaA Shares Jump After Guidance Lift

13 mei 2026, 05:47 UTC

Winsten

Germany's Merck KGaA Raises Guidance

5 mrt 2026, 06:28 UTC

Winsten

Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings

13 mei 2026, 07:56 UTC

Marktinformatie

Winsten

Merck KGaA's Guidance Raise Boosts Confidence Amid Middle East War -- Market Talk

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Raises 2026 View To Sales EUR20.4B-EUR21.4B

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Sees 2026 Organic Net Sales Growth Ranging From Flat to 3%

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Had Guided for 2026 Net Sales of EUR20B-EUR21.1B

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA 1Q Ebitda Before One-Time Items EUR1.53B

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Raises 2026 View

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA: New Guidance Assumes Stronger Life Science Momentum, Healthcare Resilience

13 mei 2026, 05:00 UTC

Winsten

Germany's Merck KGaA Says Process Solutions, Semiconductor Materials Drove 1Q Results

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA 1Q After-Tax Profit EUR669M

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA: Guidance Upgrade Is Based on Market Conditions, 1Q Performance

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Had Guided for 2026 Ebitda Before One-Time Items of EUR5.5B-EUR6B

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Sees 2026 Ebitda Before One-Time Items of EUR5.7B-EUR6.1B

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA Had Guided for 2026 Organic Net Sales to Range From of 1% Fall to 2% Rise

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA 1Q Sales EUR5.13B

13 mei 2026, 05:00 UTC

Winsten

Merck KGaA 1Q Adj EPS EUR2.11

1 apr 2026, 12:06 UTC

Acquisities, Fusies, Overnames

Merck KGaA Completes Acquisition of JSR Life Sciences' Chromatography Business

5 mrt 2026, 08:40 UTC

Marktinformatie

Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8

5 mrt 2026, 06:00 UTC

Winsten

Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA Sees 2026 Sales EUR20B-EUR21B

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA 2025 Adj EPS EUR8.34

5 mrt 2026, 06:00 UTC

Winsten

Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA Keeps Dividend at EUR2.20 a Share

5 mrt 2026, 06:00 UTC

Winsten

Merck KGaA 2025 After-Tax Profit EUR2.615B

Peer Vergelijking

Prijswijziging

Merck KGaA Prognose

Koersdoel

By TipRanks

13.91% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 138 EUR 13.91%

Hoogste 152 EUR

Laagste 112 EUR

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Merck KGaA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Gebaseerd op 8 analisten die aandelenratings hebben gegeven aan Merck KGaA - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

121.15 / 123.55Steun & Weerstand

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

108 / 345 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Merck KGaA

There is no Profile data available for MRK.BE.

Andere aandelen uit de sector

SAN

Sanofi SA

73.96

↑ +1.25%

ARGX

Argenx SE

691.6

↑ +0.03%

SHL.DE

Siemens Healthineers AG

33.51

↓-1.93%

FRE

Fresenius SE & Co KGaA

38.8

↓-0.33%

PHIA

Koninklijke Philips NV

21.75

↓-1.27%

Merck KGaA

Overzicht

Wijziging aandelenprijs

Belangrijke statistieken

Aanbevelingen

Dividenden

Marktinformatie

Nieuwssentiment

Technische score

Merck KGaA Grafiek

Gerelateerd nieuws

Peer Vergelijking

Merck KGaA Prognose

Koersdoel

Beoordelingsconsensus

Technische score

Sentiment

Financieel

Over Merck KGaA

Andere aandelen uit de sector